NEXT Oncology, an Avacare business, has expanded its services to Asia through a strategic partnership with Kansai Medica...
4D Molecular Therapeutics has announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialise ...
With the CDMO segment seeing rapid growth, how would you describe the changing profile of your clients, and how is Teiji...
German firm Boehringer Ingelheim has licensed a pre-clinical programme from Japan's Kyowa Kirin to develop a potential f...
Japan-based Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.73 b...
MEDINET Japan and Stempeutics India (a group Company of Manipal Education & Medical Group) have signed an option lic...
Japan-based Renalys Pharma and Chugai Pharmaceutical have announced a definitive stock purchase agreement, under which C...
Japan-based medtech company Olympus Corporation has announced the launch of THUNDERBEAT™ II, the next generation h...
France-based Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based prod...
China's Innovent Biologics has announced a strategic global collaboration with Japanese pharmaceutical firm Takeda to ad...
Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...
A.D.A.M. Innovations, Japan's leading private genetic testing company, and Swiss-based SOPHiA GENETICS, have announced a...
Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy® Subcutaneous...
The UK BioIndustry Association (BIA) and Japan Bioindustry Association (JBA) have signed a Memorandum of Understanding (...
Gunze Limited has announced that its wholly owned subsidiary, Gunze Medical Limited and US-based HistoSonics, Inc. have ...
Japan's startup Alpha Fusion Inc. has announced a joint initiative with the Kobe City Medical Center General Hospital (K...
Campus Create, one of Japan’s largest university-affiliated Technology Licensing Organisations (TLOs), has launche...
Germany-based Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) ...
